(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Nektar Therapeutics, Rubrik, and SentinelOne Earnings Preview

  • March 08th, 2026
  • 41 views

Las Vegas, NV / CRWE PRESS RELEASE / March 8, 2026 - Among the companies expected to release financial results on Thursday, March 12, are

Nektar Therapeutics (Nasdaq: NKTR), a biotechnology company focused on developing therapies for autoimmune disorders and cancer, will announce its financial figures for the fourth quarter and the year ended 2025 after the close of U.S. markets. Analysts expect a loss of $3.49 per share on revenue of $10.41 million. $NKTR closed Friday at $70.70, down $1.75, or 2.42%.

Rubrik, Inc. (NYSE: RBRK), a cloud data management and cybersecurity company specializing in data protection, backup, and ransomware recovery solutions, will release its fourth-quarter and fiscal year 2026 results after the closing bell. Wall Street expects a loss of $0.11 per share on revenue of $342.37 million. $RBRK ended Friday at $57.17, up $1.29, or 2.31%.

SentinelOne, Inc. (NYSE: S), a cybersecurity firm known for its AI-powered endpoint security platform, will deliver its fourth-quarter and fiscal year 2026 financial results following the market close. The consensus loss estimate stands at $0.18 per share, with revenue projected to reach $271.16 million. On Friday, $S closed at $14.19, up $0.22, or 1.57%.

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13